CTRI/2014/08/004934已完成4 期
An evaluation of the efficacy of solifenacin and darifenacin for prevention of catheter-related bladder discomfor: A prospective, randomized, placeboâ??controlled, doubleâ??blind study
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.ASA grade I and II,
- •2.Non hypertensive and non diabetic
- •3.Scheduled for surgery under general anesthesia requiring catheterization
排除标准
- •1.patients with known sensitivity to study drugs,
- •2.history of drug or alcohol abuse,
- •3.history of chronic pain or daily intake of analgesics,
- •4.pregnant or breast-feeding females,
- •5.uncontrolled medical disease (diabetes mellitus and hypertension)
- •6.impaired kidney or liver functions and
- •7.psychiatric patients
研究者
相似试验
招募中
2 期
Comparison of the efficacy of solifenacin and duloxetine in the treatment of overactive bladder diseaseIRCT20191010045047N1Kerman University of Medical Sciences60
已完成
4 期
Efficacy of Solifenacin and trospium chloride on neurogenic bladderCondition 1: stroke. Condition 2: neurogenic bladder.Cerebrovascular disease, unspecifiedNeuromuscular dysfunction of bladder, unspecifiedI67.9N31.9IRCT20160606028304N2Tabriz University of Medical Sciences201
已完成
不适用
Clinical study of Solifenacin and Imidafenacin in OAB patients with nocturiaOveractive bladderJPRN-UMIN000009137Clinical Research Support Center Kyushu80
已完成
3 期
Comparison of two treatment method in children with primary nocturnal enuresisIRCT20170509033894N3Vice Chancellor for Research and Technology of Ahvaz Jundishapur University of Medical Sciences40
招募中
1 期
BeDryDaytime urinary incontinence and overactive bladderMedDRA version: 21.1Level: LLTClassification code: 10021642Term: Incontinence of urine Class: 10038359MedDRA version: 20.0Level: LLTClassification code: 10008523Term: Childhood incontinence Class: 10038359CTIS2023-510187-13-00Region Midtjylland236